Gynodian® Depot (BAY86-5032) + BAY86-4980

Phase 3Completed
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hormone Replacement Therapy

Conditions

Hormone Replacement Therapy

Trial Timeline

May 1, 2002 → Apr 1, 2004

About Gynodian® Depot (BAY86-5032) + BAY86-4980

Gynodian® Depot (BAY86-5032) + BAY86-4980 is a phase 3 stage product being developed by Bayer for Hormone Replacement Therapy. The current trial status is completed. This product is registered under clinical trial identifier NCT00463450. Target conditions include Hormone Replacement Therapy.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00463450Phase 3Completed